Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,502.00    -48.00 (-3.10%)
Bid:
1,494.00
Ask:
1,498.00
Spread: 4.00 (0.268%)
Market Cap: £783.50m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Replacement - Director Dealings

11 Jan 2018 15:41

RNS Number : 6566B
M. P. Evans Group PLC
11 January 2018
 

The following amendments have been made to the 'Director Dealings' announcement released on 22 June 2017 at 17.54 under RNS No 9517I.

In the PDMR dealing disclosure form, the period within which the options are exercisable should have been 3 April 2020 to 2 April 2027 rather than 3 April 2020 to 3 April 2030. All other details remain unchanged.

The full amended text is shown below.

 

 

M.P. EVANS GROUP PLC

("Company" or "M.P. Evans")

 

GRANT OF SHARE OPTIONS

 

On 8 June 2017, the Company granted an option, under the M.P. Evans Group PLC Long Term Incentive Scheme, to each of Mr Tristan Price, the Chief Executive, and Mr Matthew Coulson, the Finance Director, to subscribe respectively for 16,347 and 8,333 ordinary shares in the Company at a nil cost exercise price. These options are exercisable at any time between 3 April 2020 and 2 April 2027.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

 

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

1. Tristan Price, Chief Executive

2. Matthew Coulson, Finance Director

2

Reason for the notification

a)

Position/status

PDMRs of the Company

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

M.P. Evans Group plc

b)

LEI

2138003IBXJUCR4SZG26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10p each in the capital of M.P. Evans Group PLC

Identification code

ISIN: GB0007538100

b)

Nature of the transaction

Grant of options over Ordinary shares

c)

Price(s) and volume(s)

Exercise Prices per share

Volumes

1. Nil Cost Options

2. Nil Cost Options

 

1. 16,347

2. 8,333

 

d)

Aggregated information

- Aggregated volume

- Price

Aggregated volume:

Price: Nil cost options

e)

Date of the transaction

8 June 2017

f)

Place of the transaction

Outside a trading venue

 

Enquiries:

M.P. Evans Group PLC Telephone: +44(0)1892 516333

Peter Hadsley-Chaplin, Chairman

Tristan Price, Chief Executive

Matthew Coulson, Finance Director

 

Peel Hunt LLP Telephone: +44 (0)207418 8900

Dan Webster

George Sellar

Nicole McDougall

 

Hudson Sandler Telephone: +44 (0)207 796 4133

Charlie Jack

Bertie Berger

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGGUGPGUPRGAG
Date   Source Headline
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:30 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
26th May 20262:42 pmRNSShare Buyback Programme
20th May 202611:26 amRNSIndonesian commodity exporting
12th May 20262:52 pmRNSAGM Arrangements
1st Apr 20265:40 pmRNS2025 Annual Report
26th Mar 202610:16 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results 2025
5th Mar 20267:00 amRNSNotice of Results
23rd Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Jan 20267:00 amRNS2025 Crop and production
16th Jan 20261:05 pmRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSDirector/PDMR Shareholding
18th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 202512:58 pmRNSPublication of 2024 ESG report
2nd Dec 20251:14 pmRNSCompany update
1st Dec 20257:00 amRNSAppointment of joint broker
10th Nov 20257:00 amRNSStrong pricing during second half of 2025
28th Oct 20255:33 pmRNSHolding(s) in Company
22nd Sep 20253:26 pmRNSAIM Rule 20
15th Sep 20257:00 amRNSHalf-year Report
27th Aug 20257:00 amRNSNotice of interim results & investor presentation
29th Jul 20257:00 amRNSPublication of TCFD report
24th Jul 20257:00 amRNS2025 H1 crop and production
14th Jul 202510:07 amRNSAcquisition
7th Jul 20254:54 pmRNSDirector/PDMR Shareholding
30th Jun 20254:30 pmRNSTotal Voting Rights
25th Jun 202511:18 amRNSIssue of Equity
18th Jun 20257:00 amRNSShare buyback programme
13th Jun 20251:45 pmRNSResult of AGM
13th Jun 20257:00 amRNSAGM Statement
12th Jun 20254:50 pmRNSAppointment to board roles
5th Jun 20257:00 amRNSAGM update
14th May 20257:00 amRNSDirectorate Change
22nd Apr 20255:33 pmRNSDirector/PDMR Shareholding
16th Apr 202511:00 amRNSAcquisition
31st Mar 20254:02 pmRNSPosting of Annual Report
25th Mar 20257:00 amRNSFinal Results
21st Mar 20257:00 amRNSDirector retirement
5th Mar 20257:00 amRNSNotice of Results and investor presentation
20th Jan 20253:05 pmRNSDirector/PDMR Shareholding
20th Jan 20257:00 amRNSCrop and production
2nd Jan 202511:31 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.